Stephen currently serves as Investment Director of Co-High, covering investments in the Healthcare sector. Prior to joining Co-High, Stephen was a senior consultant at Mckinsey & Co., advising global 500 pharmaceutical and insurance clients on topics such as corporate strategy, R&D strategy, and corporate venture capital. Stephen has a Ph.D. in Genetics from The University of Cambridge and a B.Sc in Biochemistry from Imperial College London. While at Cambridge he was also a Hong Kong Croucher scholar.